Category: Clinical Breakthroughs
-
Examining Kinase Inhibitors to Treat Chronic Myeloid Leukemia
Francis Giles, MD, chief of Hematology/Oncology in the Department of Medicine, led a clinical study to test the efficacy and safety of a kinase inhibitor for the treatment of chronic myeloid leukemia.
-
Investigating Outcomes and Predictors of Congenital Heart Diseases
Nina Gotteiner, MD, associate professor of Pediatrics in the Division of Cardiology, studied the outcomes and predictors of fetuses diagnosed with Epstein anomaly or tricuspid valve dysplasia.
-
Blood Pressure Medication Can’t Undo All Damage
Many patients on antihypertensive medications are at greater risk of cardiovascular disease, despite controlled numbers, according to a new Northwestern Medicine study.
-
RNA Editing Technique Treats Severe Form of Muscular Dystrophy
An RNA editing technique called ‘exon skipping’ has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment.
-
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
In a phase three clinical trial, a new enzyme replacement therapy resulted in a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency.
-
Coffee Associated With Colon Cancer Survival
A recent study shows that patients treated for colon cancer who regularly drank caffeinated coffee had lower rates of cancer recurrence and mortality.
-
Probing Patient Beliefs About Painkiller Addiction
Emergency department patients have a range of beliefs and attitudes about the risk of becoming addicted to prescribed opioids, according to a recent study authored by a Feinberg medical student.
-
Clinical Trial Compares Lymphoma Regimens
A new study co-authored by a Northwestern Medicine scientist found no significant difference between two popular therapy regimens in patients with a subset of Hodgkin lymphoma.
-
Low Dose Beta-Blockers As Effective As High Dose After a Heart Attack
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
-
Evaluating Exercise to Reduce Cognitive Decline
Older adults who exercised regularly did not have better cognitive function than those who attended health education workshops, according to a study co-authored by Northwestern Medicine investigator Mary McDermott, MD, ’92 GME.
